Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Assets (2016 - 2025)

Historic Assets for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $294.8 million.

  • Perspective Therapeutics' Assets fell 2462.67% to $294.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $294.8 million, marking a year-over-year decrease of 2462.67%. This contributed to the annual value of $341.1 million for FY2024, which is 24844.98% up from last year.
  • As of Q3 2025, Perspective Therapeutics' Assets stood at $294.8 million, which was down 2462.67% from $310.7 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Assets registered a high of $391.2 million during Q3 2024, and its lowest value of $58.1 million during Q4 2022.
  • Moreover, its 5-year median value for Assets was $110.5 million (2023), whereas its average is $174.5 million.
  • Per our database at Business Quant, Perspective Therapeutics' Assets surged by 75619.94% in 2021 and then crashed by 2462.67% in 2025.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Assets stood at $67.3 million in 2021, then dropped by 13.62% to $58.1 million in 2022, then surged by 68.51% to $97.9 million in 2023, then soared by 248.45% to $341.1 million in 2024, then decreased by 13.57% to $294.8 million in 2025.
  • Its last three reported values are $294.8 million in Q3 2025, $310.7 million for Q2 2025, and $329.3 million during Q1 2025.